HeyJaredHeart Matters
Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health.
- Indexed episodes, last 90 days
- 18
- Latest publication
- Sep 25, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 10, 2026
Latest episodes
Navigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery (opens the original)
Read excerpt
Host: Brian P. McDonough, MD, FAAFP Guest: Ahmet Kilic, MD FACS When cardiothoracic surgery can’t wait, chronic anticoagulation can further complicate an already complex clinical picture. In this conversation with Dr. Brian McDonough, Dr. Ahmet Kilic explores the factors that can help inform anticoagulation reversal decisions in time-sensitive scenarios. Dr. Kilic is a Professor of Clinical Cardiac Surgery and the Program Director for the Cardiothoracic Surgery Residency Program at Johns Hopkins
Improving ATTR-CM Care Through Community-Specialist Partnership (opens the original)
Read excerpt
Guest: Alex Reyentovich, MD Community providers and amyloidosis specialists each play a vital role in diagnosing and managing transthyretin amyloid cardiomyopathy (ATTR-CM). Join Dr. Alex Reyentovich as he explains how this partnership can improve both patient care and diagnosis rates. Dr. Reyentovich is a Professor in the Department of Medicine at NYU Grossman School of Medicine and the Co-Director of the Amyloidosis Program at the Perlmutter Cancer Center at NYU Langone Health.
Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights (opens the original)
Read excerpt
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Akshay Kumar, MD In cardiothoracic surgery, the need for anticoagulation reversal can arise quickly, and the path forward isn’t always clear. In this case-based discussion with Dr. Brian McDonough, Dr. Akshay Kumar shares his perspective on making anticoagulation reversal decisions across a range of urgent and complex surgical scenarios. Dr. Kumar is a Clinical Assistant Professor in the Department of Cardiothoracic Surgery at the NYU Grossman Scho
Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia (opens the original)
Read excerpt
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Andrew Freeman, MD, FACC, FACP In this episode of Heart Matters , Dr. Charles Turck is joined by Dr. Andrew Freeman to take a case-based look at severe hypertriglyceridemia and explore how the 2026 American College of Cardiology/American Heart Association Multisociety guideline on dyslipidemia management can help inform clinical decision-making. Together, Dr. Turck and Dr. Freeman follow a hypothetical patient over the course of their treatment jou
Updated AACE Guidance on Managing Dyslipidemia in T2D (opens the original)
Read excerpt
Guest: Scott D. Isaacs, MD FACP, FACE Dyslipidemia is a major driver of cardiovascular risk in patients with type 2 diabetes (T2D), and lipid management is a key component of the 2026 AACE diabetes algorithm. Join Dr. Scott Isaacs as he reviews new recommendations on LDL-C goals and individualized care in this population. Dr. Isaacs is the Immediate Past President of the American Association of Clinical Endocrinology and an Associate Professor of Medicine at Emory University School of Medicine.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.